FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076607631> ?p ?o ?g. }

• W2076607631 endingPage "354" @default.
• W2076607631 startingPage "347" @default.
• W2076607631 abstract "The aim of this study was to investigate the expression of the protein tyrosine phosphatases (PTP) PRL-1, PRL-2, and PRL-3 in human breast cancer and to evaluate its clinical and prognostic significance. PRL-PTP mRNA expression was examined in malignant (n = 7) and nonmalignant (n = 7) cryoconserved breast tissue samples as well as in eight breast cancer cell lines by RT-PCR. Furthermore, protein expression of PRL-3 was analysed semiquantitatively by immunohistochemistry in ductal breast carcinoma in situ (n = 135) and invasive breast cancer (n = 147) by use of tissue microarray technology (TMA). In 24 lymph node-positive patients we selected the corresponding lymph node metastases for analysis of PRL-3 expression, and a validation set (n = 99) of invasive breast cancer samples was examined. Staining results were correlated with clinicopathological parameters and long-term follow-up. PRL-3 mRNA expression was significantly higher in malignant compared to benign breast tissue. For PRL-1 and PRL-2 expression no significant differences were observed. Staining of TMAs showed PRL-3 expression in 85.9% ductal carcinoma in situ and 75.5% invasive breast carcinomas. Analysis of survival parameters revealed a shorter disease-free survival (DFS) in patients with PRL-3-positive carcinomas, and in particular a significantly shorter DFS in nodal-positive patients with PRL-3 overexpressing tumours as compared to PRL-3-negative breast carcinomas (66+/-7 months (95% CI, 52-80) vs 97+/-9 months (95% CI, 79-115); P = 0.032). Moreover, we found a more frequent expression of PRL-3 in lymph node metastases as compared to the primary tumours (91.7 vs 66.7%; P = 0.033). Our results suggest that PRL-3 might serve as a novel prognostic factor in breast cancer, which may help to predict an adverse disease outcome." @default.
• W2076607631 created "2016-06-24" @default.
• W2076607631 creator A5034776080 @default.
• W2076607631 creator A5049038203 @default.
• W2076607631 creator A5054162743 @default.
• W2076607631 creator A5056795901 @default.
• W2076607631 creator A5064115012 @default.
• W2076607631 creator A5079707905 @default.
• W2076607631 date "2006-07-11" @default.
• W2076607631 modified "2023-10-06" @default.
• W2076607631 title "Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer" @default.
• W2076607631 cites W1583605194 @default.
• W2076607631 cites W168637747 @default.
• W2076607631 cites W1961026612 @default.
• W2076607631 cites W1983855612 @default.
• W2076607631 cites W1985027324 @default.
• W2076607631 cites W1986266121 @default.
• W2076607631 cites W1988627168 @default.
• W2076607631 cites W1992235706 @default.
• W2076607631 cites W2000000541 @default.
• W2076607631 cites W2006061235 @default.
• W2076607631 cites W2010871781 @default.
• W2076607631 cites W2015998760 @default.
• W2076607631 cites W2024425168 @default.
• W2076607631 cites W2024619701 @default.
• W2076607631 cites W2027064373 @default.
• W2076607631 cites W2033168226 @default.
• W2076607631 cites W2034269086 @default.
• W2076607631 cites W2037769103 @default.
• W2076607631 cites W2037881182 @default.
• W2076607631 cites W2039653005 @default.
• W2076607631 cites W2047883221 @default.
• W2076607631 cites W2056479560 @default.
• W2076607631 cites W2064734372 @default.
• W2076607631 cites W2065977830 @default.
• W2076607631 cites W2078102016 @default.
• W2076607631 cites W2100226365 @default.
• W2076607631 cites W2105053096 @default.
• W2076607631 cites W2106102676 @default.
• W2076607631 cites W2106112270 @default.
• W2076607631 cites W2116199502 @default.
• W2076607631 cites W2121555447 @default.
• W2076607631 cites W2123129045 @default.
• W2076607631 cites W2132025770 @default.
• W2076607631 cites W2144257911 @default.
• W2076607631 cites W2146101976 @default.
• W2076607631 cites W2148566055 @default.
• W2076607631 cites W2157833929 @default.
• W2076607631 cites W2161428561 @default.
• W2076607631 cites W2172212550 @default.
• W2076607631 cites W2198974858 @default.
• W2076607631 cites W2252547320 @default.
• W2076607631 cites W4231265894 @default.
• W2076607631 cites W4255042798 @default.
• W2076607631 doi "https://doi.org/10.1038/sj.bjc.6603261" @default.
• W2076607631 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2360632" @default.
• W2076607631 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16832410" @default.
• W2076607631 hasPublicationYear "2006" @default.
• W2076607631 type Work @default.
• W2076607631 sameAs 2076607631 @default.
• W2076607631 citedByCount "105" @default.
• W2076607631 countsByYear W20766076312012 @default.
• W2076607631 countsByYear W20766076312013 @default.
• W2076607631 countsByYear W20766076312014 @default.
• W2076607631 countsByYear W20766076312015 @default.
• W2076607631 countsByYear W20766076312016 @default.
• W2076607631 countsByYear W20766076312017 @default.
• W2076607631 countsByYear W20766076312018 @default.
• W2076607631 countsByYear W20766076312019 @default.
• W2076607631 countsByYear W20766076312020 @default.
• W2076607631 countsByYear W20766076312021 @default.
• W2076607631 countsByYear W20766076312022 @default.
• W2076607631 countsByYear W20766076312023 @default.
• W2076607631 crossrefType "journal-article" @default.
• W2076607631 hasAuthorship W2076607631A5034776080 @default.
• W2076607631 hasAuthorship W2076607631A5049038203 @default.
• W2076607631 hasAuthorship W2076607631A5054162743 @default.
• W2076607631 hasAuthorship W2076607631A5056795901 @default.
• W2076607631 hasAuthorship W2076607631A5064115012 @default.
• W2076607631 hasAuthorship W2076607631A5079707905 @default.
• W2076607631 hasBestOaLocation W20766076311 @default.
• W2076607631 hasConcept C121608353 @default.
• W2076607631 hasConcept C126322002 @default.
• W2076607631 hasConcept C142724271 @default.
• W2076607631 hasConcept C143998085 @default.
• W2076607631 hasConcept C193270364 @default.
• W2076607631 hasConcept C204232928 @default.
• W2076607631 hasConcept C2777546739 @default.
• W2076607631 hasConcept C2778001805 @default.
• W2076607631 hasConcept C2780849966 @default.
• W2076607631 hasConcept C2780862961 @default.
• W2076607631 hasConcept C3018521938 @default.
• W2076607631 hasConcept C530470458 @default.
• W2076607631 hasConcept C71924100 @default.
• W2076607631 hasConcept C86803240 @default.
• W2076607631 hasConceptScore W2076607631C121608353 @default.
• W2076607631 hasConceptScore W2076607631C126322002 @default.
• W2076607631 hasConceptScore W2076607631C142724271 @default.

• next